Extended Follow-Up Confirms Efficacy of First-Line Pembrolizumab Plus Lenvatinib in Advanced Non–Clear Cell RCC.

Subjects

Subjects :

*CANCER treatment
*PEMBROLIZUMAB
*TREATMENT effectiveness
*CANCER chemotherapy
*ADJUVANT treatment of cancer

Details

Language :

English

ISSN :

23745347

Volume :

25

Issue :

5

Database :

Academic Search Index

Journal :

OncologyLive

Publication Type :

Academic Journal

Accession number :

175882302